Drugs that contain Sodium Oxybate

1. Drug name - XYREM

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8731963 JAZZ PHARMS Sensitive drug distribution system and method Dec, 2022

(2 months from now)

US8731963

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method Jun, 2023

(8 months from now)

US7668730 JAZZ PHARMS Sensitive drug distribution system and method Jun, 2024

(1 year, 8 months from now)

US7668730

(Pediatric)

JAZZ PHARMS Sensitive drug distribution system and method Dec, 2024

(2 years from now)

US10864181 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US10213400 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US9486426 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US9050302 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US8772306 JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Mar, 2033

(10 years from now)

US8772306

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Sep, 2033

(10 years from now)

US9486426

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Sep, 2033

(10 years from now)

US9050302

(Pediatric)

JAZZ PHARMS Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Sep, 2033

(10 years from now)

Treatment: Method of treating a patient with a prescription drug using a computer database in a computer system for distribution; Method of treating excessive daytime sleepiness and/or cataplexy in narcolepsy patients with sodium oxybate when divalproex sodium is concomitantly administered.; Method of reducing adverse effects in patients suffering from excessive daytime sleepiness and/or cataplexy in narcolepsy who are concomitantly administered sodium oxybate and divalproex sodium

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
0.5GM/ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.